scholarly journals In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus

Molecules ◽  
2019 ◽  
Vol 24 (9) ◽  
pp. 1723 ◽  
Author(s):  
Shi-Fang Li ◽  
Mei-Jiao Gong ◽  
Yue-Feng Sun ◽  
Jun-Jun Shao ◽  
Yong-Guang Zhang ◽  
...  

Foot-and-mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals, which has significant economic consequences in affected countries. As the currently available vaccines against FMD provide no protection until 4–7 days post-vaccination, the only alternative method to control the spread of FMD virus (FMDV) during outbreaks is the application of antiviral agents. Hence, it is important to identify effective antiviral agents against FMDV infection. In this study, we found that mizoribine has potent antiviral activity against FMDV replication in IBRS-2 cells. A time-of-drug-addition assay demonstrated that mizoribine functions at the early stage of replication. Moreover, mizoribine also showed antiviral effect on FMDV in vivo. In summary, these results revealed that mizoribine could be a potential antiviral drug against FMDV.

2019 ◽  
Vol 116 ◽  
pp. 108982 ◽  
Author(s):  
Shi-fang Li ◽  
Mei-jiao Gong ◽  
Yue-feng Sun ◽  
Jun-jun Shao ◽  
Yong-guang Zhang ◽  
...  

2019 ◽  
Vol 114 ◽  
pp. 226-232
Author(s):  
Shi-fang Li ◽  
Mei-jiao Gong ◽  
Jun-jun Shao ◽  
Yue-feng Sun ◽  
Yong-guang Zhang ◽  
...  

2020 ◽  
Vol 94 (13) ◽  
Author(s):  
Gisselle N. Medina ◽  
Paul Azzinaro ◽  
Elizabeth Ramirez-Medina ◽  
Joseph Gutkoska ◽  
Ying Fang ◽  
...  

ABSTRACT Foot-and-mouth disease virus (FMDV) leader proteinase (Lpro) affects several pathways of the host innate immune response. Previous studies in bovine cells demonstrated that deletions (leaderless [LLV]) or point mutations in Lpro result in increased expression of interferon (IFN) and IFN-stimulated genes (ISGs), including, among others, the ubiquitin-like protein modifier ISG15 and the ubiquitin specific peptidase USP18. In addition to its conventional papain-like protease activity, Lpro acts as a deubiquitinase (DUB) and deISGylase. In this study, we identified a conserved residue in Lpro that is involved in its interaction with ISG15. Mutation W105A rendered Escherichia coli-expressed Lpro unable to cleave the synthetic substrate pro-ISG15 while preserving cellular eIF4G cleavage. Interestingly, mutant FMDV W105A was viable. Overexpression of ISG15 and the ISGylation machinery in porcine cells resulted in moderate inhibition of FMDV replication, along with a decrease of the overall state of ISGylation in wild-type (WT)-infected cells. In contrast, reduced deISGylation was observed upon infection with W105A and leaderless virus. Reduction in the levels of deubiquitination was also observed in cells infected with the FMDV LproW105A mutant. Surprisingly, similarly to WT, infection with W105A inhibited IFN/ISG expression despite displaying an attenuated phenotype in vivo in mice. Altogether, our studies indicate that abolishing/reducing the deISGylase/DUB activity of Lpro causes viral attenuation independently of its ability to block the expression of IFN and ISG mRNA. Furthermore, our studies highlight the potential of ISG15 to be developed as a novel biotherapeutic molecule against FMD. IMPORTANCE In this study, we identified an aromatic hydrophobic residue in foot-and-mouth disease virus (FMDV) leader proteinase (Lpro) (W105) that is involved in the interaction with ISG15. Mutation in Lpro W105 (A12-LproW105A) resulted in reduced deISGylation in vitro and in porcine-infected cells. Impaired deISGylase activity correlated with viral attenuation in vitro and in vivo and did not affect the ability of Lpro to block expression of type I interferon (IFN) and other IFN-stimulated genes. Moreover, overexpression of ISG15 resulted in the reduction of FMDV viral titers. Thus, our study highlights the potential use of Lpro mutants with modified deISGylase activity for development of live attenuated vaccine candidates, and ISG15 as a novel biotherapeutic against FMD.


2005 ◽  
Vol 17 (2) ◽  
pp. 242 ◽  
Author(s):  
K. de Haas ◽  
I. Luther ◽  
D. Gerber

Transferred embryos carry the risk of being vehicles of organisms causing diseases. Currently, the risk of in vitro-produced (IVP) embryos is more difficult to assess than the risk of in vivo-derived embryos, since less research has been published on the former. Foot and mouth disease virus (FMDV) is extremely sensitive to a low pH and is likely to be destroyed if embryos are exposed to a low pH for a short time. 2-(N-Morphalino)-ethanesulfonic acid (MES); an organic buffer with pKa 6.1; Sigma, South Africa, M2933) as been shown to destroy FMDV at a rate of 90% per minute at pH 6 and at a rate of 90% per second at pH 5 (Acharya et al. 1990 Vet. Microbiol. 23, 21–34; Thomson “Foot-and-mouth disease,” in Infectious Diseases of Livestock with Special Reference to Southern Africa, ed. Coetzer JAW, Thomson GR, and Tustin RC, Oxford University Press, Cape Town, 825–852). The aim of this study was to test whether exposing bovine oocytes and IVP zygotes to the organic buffer MES, buffered at pH 5.5, is detrimental to the development of bovine IVP embryos. IVM, IVF, and IVC was carried out with 1367 oocytes as described earlier [Jooste et al. 2003 Theriogenology 59, 443]. Oocytes were divided into three groups: 484 were used as controls (no MES exposure); 437 were in a maximal exposure group (MAX), i.e. MES treatment after washing of oocytes, after IVM and after IVF, and 446 had a minimal exposure (MIN), i.e. MES treatment after IVF only. To treat the oocytes with MES, 100 oocytes (from ten droplets) were drawn into a pipette in a maximal volume of 100 μL, and placed in 3 mL of MES, swirled around for 10 s, drawn up again in a maximal volume of 100 μL, and placed in 3 mL of culture medium. Oocytes or zygotes were then washed five times in culture medium before being processed through IVM, IVF, or IVC depending on their stage. Exposure of oocytes to MES varied from 30 to 60 s (10 s swirling and a variable time thereafter to pick up). A chi-square test was used to test for differences in cleavage and Day 7 blastocyst yield between control and treatment groups (P < 0.05). Cleavage (70%; 340/484) and blastocyst yield (32%; 156/484) in the control group were not different from those in MIN (68%; 304/446, and 29%; 131/446, respectively), but were significantly higher than for MAX (57%; 249/437, and 18%; 79/437, respectively). In MAX the MES had a harsh effect on the cumulus cells, making them granular and clumpy in appearance. Oocytes treated in MES solution adhered to the bottom of the dish, which made their handling difficult. Exposure time in MES was therefore variable and longer than initially planned. It is concluded that bovine IVP embryos can be exposed to MES without detrimental effect. Treatment with MAX still resulted in blastocysts but it did not yield good numbers. In future trials, treated dishes should be used to prevent oocyte and zygote adherence. Further research is needed to test whether FMDV can be removed from bovine IVP embryos with the described method.


2018 ◽  
Vol 91 (2) ◽  
pp. 208-214 ◽  
Author(s):  
Shi‐Fang Li ◽  
Fu‐Rong Zhao ◽  
Mei‐Jiao Gong ◽  
Jun‐Jun Shao ◽  
Yin‐Li Xie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document